• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Natera Inc (NQ: NTRA )

    120.27 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 27, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 120.27
    Bid (Size) 115.01 (1)
    Ask (Size) 127.25 (1)
    Prev. Close 120.27
    Today's Range 120.27 - 120.27
    52wk Range 36.90 - 124.83
    Shares Outstanding 123,681,432
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Peeling Back The Layers: Exploring Natera Through Analyst Insights
    Via Benzinga
    Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
    The recent stock market dip provided some discounts. 
    Via The Motley Fool

    Performance

    YTD
    +94.23%
    +94.23%
    1 Month
    +15.90%
    +15.90%
    3 Month
    +9.77%
    +9.77%
    6 Month
    +57.92%
    +57.92%
    1 Year
    +116.66%
    +116.66%

    More News

    Read More
    Shopify, Palantir And Uber Are Among Top 10 Large Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
    Via Benzinga
    Forecasting The Future: 6 Analyst Projections For Natera
    Via Benzinga
    NTRA Stock Earnings: Natera Beats EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    $100 Invested In Natera 5 Years Ago Would Be Worth This Much Today
    Via Benzinga
    (NTRA) - Analyzing Natera's Short Interest
    Via Benzinga
    Here's How Much You Would Have Made Owning Natera Stock In The Last 5 Years
    Via Benzinga
    $1000 Invested In This Stock 5 Years Ago Would Be Worth $4,300 Today
    Via Benzinga
    Natera Reports Second Quarter 2024 Financial Results
    From Natera, Inc.
    Via Business Wire
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Natera to Participate in the Canaccord Genuity 44th Annual Growth Conference
    From Natera, Inc.
    Via Business Wire
    Natera to Report its Second Quarter 2024 Results on August 8, 2024
    From Natera, Inc.
    Via Business Wire
    $100 Invested In Natera 5 Years Ago Would Be Worth This Much Today
    Via Benzinga
    $1000 Invested In This Stock 5 Years Ago Would Be Worth $4,400 Today
    Via Benzinga
    Breaking Down Natera: 10 Analysts Share Their Views
    Via Benzinga
    New MultiCenter Prospective Study Demonstrates Signatera’s Clinical Utility in Merkel Cell Carcinoma
    From Natera, Inc.
    Via Business Wire
    The 3 Best Gene Editing Stocks to Buy in July 2024
    Via InvestorPlace
    Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy
    From Natera, Inc.
    Via Business Wire
    Trading SMID Biotech Stocks In A Volatile Market
    Via Talk Markets
    Natera Announces DECIPHER: A Phase II, Single-Arm Adjuvant Trial in Gastroesophageal Cancer
    From Natera, Inc.
    Via Business Wire
    Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests
    Via MarketBeat
    Natera Launches Differentiated New Feature for Prospera™ Heart Test, Enhancing Detection of Rejection for Transplant Patients
    From Natera, Inc.
    Via Business Wire
    Amazon, Natera And A Financial Stock: CNBC's 'Final Trades'
    Via Benzinga
    Natera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
    From Natera, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.